Javier Marcelo Di Noia

15PUBLICATIONS
78CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 12, 2026
DOT1L activity limits transcription elongation velocity and favors RNAPII pausing to facilitate mutagenesis by AID.

Poorani Ganesh Subramani, Noé Seija, Jana Ridani

|Nov 11, 2025
Ubiquitination of MHC class II molecules regulates B-cell development and response to antigens in mice.

Maxime Raymond, Renaud Balthazard, Astrid Zahn

|Jun 12, 2025
CDADC1 is a vertebrate-specific dCTP deaminase that metabolizes gemcitabine and decitabine to prevent cellular toxicity.

Marcelo M Rodriguez, Debashree Chatterjee, Johanna Guerry

|May 14, 2024
Conserved role of hnRNPL in alternative splicing of epigenetic modifiers enables B cell activation.

Poorani Ganesh Subramani, Jennifer Fraszczak, Anne Helness

|Apr 16, 2024
APOBEC2 safeguards skeletal muscle cell fate through binding chromatin and regulating transcription of non-muscle genes during myoblast differentiation.

J Paulo Lorenzo, Linda Molla, Elias Moris Amro

Pageof 3